Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Trump says he could jettison drug czar pick

Published 10/16/2017, 08:45 PM
Updated 10/16/2017, 08:45 PM
© Reuters. U.S. President Donald Trump walks to Air Force One as he departs for Greenville, South Carolina, from Joint Base Andrews

WASHINGTON (Reuters) - U.S. President Donald Trump said on Monday he would review a report that his nominee for drug czar championed a law that weakened the government's ability to fight the nation's opioid epidemic, and said he could consider jettisoning the pick.

"We're going to look into the report," Trump told reporters at the White House.

Asked if the report had undercut his confidence in his nominee to head the Office of National Drug Control Policy, Representative Tom Marino, Trump said: "I have not spoken to him, but I will speak to him, and I'll make that determination.

"If I think it's 1 percent negative to doing what we want to do, I will make a change, yes," he added.

Marino's office did not immediately return a request for comment.

The report by the Washington Post and CBS described how Marino introduced and helped push through industry-backed legislation that undercut the Drug Enforcement Administration's ability to freeze suspicious shipments of pain pills from drug companies.

A number of Democrats called for Trump to abandon his nominee in the wake of the report.

"Congressman Marino no longer has my trust or that of the public that he will aggressively pursue the fight against opioid abuse," Democratic Senator Joe Manchin said in a statement. Manchin's state of West Virginia has been hit hard by the opioid crisis.

In his remarks to reporters, Trump suggested he would be open to changing the law that Marino, a fellow Republican, helped push through and said he would make good on an earlier promise to declare the opioid epidemic a national emergency.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"We are going to be doing that next week," he said, calling the crisis a "massive problem."

Opioids were involved in more than 33,000 deaths in the United States in 2015, the last year of publicly available data, according to the Centers for Disease Control and Prevention. Overdoses from the category of drugs nearly quadrupled between 1999 and 2015, the CDC said.

Latest comments

if you get chance, check out you tube video posted today of president trump stopping his caravan, hopping out of  protected auto, and going right into the south carolina crowd. no fear whatsoever. he was in the crowd for almost 10 minutes. protective staff were worried i'm sure, but president didn't blink. it was great to watch. people love the guy and you can easily see how happy the president is among the crowds.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.